For research use only. Not for therapeutic Use.
Digoxigenin monodigitoxoside is a Na+/K+ ATPase inhibitor and cardiac glycoside metabolite of digoxin.
| Catalog Number | R012544 |
| CAS Number | 5352-63-6 |
| Synonyms | 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one |
| Molecular Formula | C29H44O8 |
| Purity | ≥95% |
| InChI | InChI=1S/C29H44O8/c1-15-26(33)22(30)13-25(36-15)37-18-6-8-27(2)17(11-18)4-5-20-21(27)12-23(31)28(3)19(7-9-29(20,28)34)16-10-24(32)35-14-16/h10,15,17-23,25-26,30-31,33-34H,4-9,11-14H2,1-3H3/t15-,17-,18+,19-,20-,21+,22+,23-,25+,26-,27+,28+,29+/m1/s1 |
| InChIKey | JFSXBMIFXZFKHD-ZDDLGXCGSA-N |
| SMILES | CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)O |
| Reference | [1]. De Pover A, et al. Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides. Naunyn Schmiedebergs Arch Pharmacol. 1982 Nov;321(2):135-9. |
